Handbook of Clinical Neurology Andrews Jinsy A., Shefner Jeremy M., Clinical neurophysiology of anterior horn cell disorders [Book Chapter] 2019
Publications
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Shefner Jeremy M., Malik Fady I., Andrews Jinsy A., Meng Lisa, Rudnicki Stacy A., Wolff Andrew A., Cockroft Bettina M., Cudkowicz Merit E., Hardiman Orla, Lee Jacqueline H., A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis 20:7-8, p. 584 - 594 2019
Neurology Andrews Jinsy A., Bruijn Lucie I., Shefner Jeremy M., ALS drug development guidances and trial guidelines: Consensus and opportunities for alignment 93:2, p. 66 - 71 2019
Neurology Darras Basil T., Montes Jacqueline, Chiriboga Claudia A., Iannaccone Susan T., Swoboda Kathryn J., Mignon Laurence, Xia Shuting, Bennett C. Frank, Bishop Kathie M., Shefner Jeremy M., Gheuens Sarah, De Vivo Darryl C., Green Allison M., Sun Peng, Bhan Ishir, Schneider Eugene, Farwell Wildon, Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies 92:21, p. e2492 - e2506 2019
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Rutkove Seward B., Qi Kristin, Liss Julie, Berisha Visar, Shefner Jeremy M., Shelton Kerisa, ALS longitudinal studies with frequent data collection at home: study design and baseline data 20:1-2, p. 61 - 67 2019
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Shefner Jeremy M., Benatar Michael, Rutkove Seward B., Caress James B., David William S., Cartwright Michael S., Macklin Eric A., Bohorquez Jose L., Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system 19:7-8, p. 555 - 561 2018
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Lechtzin Noah, Shefner Jeremy, Van den Berg Leonard H., Andrews Jinsy A., Genge Angela, Cudkowicz Merit E., Mitsumoto Hiroshi, Mora Jesus S., Hardiman Orla, de Carvalho Mamede, Respiratory measures in amyotrophic lateral sclerosis 19:5-6, p. 321 - 330 2018
European Journal of Neurology Smith R. A., Pattee G. L., Macklin E. A., Myers K. J., Goslin K. L., Meekins G. D., Green J. R., Shefner J. M., Pioro E. P., Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale) 25:7, p. 907 - e66 2018
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Andrews Jinsy A., Lee Jacqueline, Cudkowicz Merit E., Hardiman Orla, Meng Lisa, Bian Amy, Wolff Andrew A., Malik Fady I., Shefner Jeremy M., VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics 19:3-4, p. 259 - 266 2018
Brooks Benjamin Rix, Jorgenson James A, Newhouse Barbara J, Shefner Jeremy M, Agnese Wendy, Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussion 2018
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Meng Lisa, Andrews Jinsy, Bian Amy, Jordan Scott, Wolff Andrew, Shefner Jeremy M., Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance 19:1-2, p. 134 - 142 2018
JAMA Neurology Andrews Jinsy A., Bozik Michael E., Kulke Sarah F., Rudnicki Stacy A., Wolff Andrew A., Malik Fady I., Shefner Jeremy M., Meng Lisa, Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis 75:1, p. 58 - 58 2018
Presentations
Invited Speaker, 2019 California ALS Summit, Irvine CA. 2019